國立高雄大學圖資館 |

Language: English

Back

Diabetes and COVID-19considerations and clinical management /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Diabetes and COVID-19edited by Alyson K. Myers.
Reminder of title:	considerations and clinical management /
other author:	Myers, Alyson K.
Published:	Cham :Springer International Publishing :2023.
Description:	xviii, 219 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	COVID-19 (Disease)Complications
Online resource:	https://doi.org/10.1007/978-3-031-28536-3
ISBN:	9783031285363$q(electronic bk.)

Diabetes and COVID-19considerations and clinical management /
Diabetes and COVID-19considerations and clinical management /[electronic resource] :edited by Alyson K. Myers. - Cham :Springer International Publishing :2023. - xviii, 219 p. :ill. (chiefly col.), digital ;24 cm. - Contemporary endocrinology,2523-3793. - Contemporary endocrinology..

COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention -- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance -- Risk of COVID-19 in Persons with Diabetes -- Pathophysiology of Lung Dysfunction in Diabetes -- Diabetic kidney disease and COVID-19 -- The Impact of COVID-19 on Diabetic Foot Ulcers -- Co-morbid obesity and its impact on diabetes and COVID-19 -- Overview of Inpatient Mgt of Diabetes and COVID 19 -- Management of critically ill persons with COVID-19 and diabetes -- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes -- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19) -- COVID-19 Vaccination in Persons with Diabetes -- COVID-19 Vaccination in Persons with Diabetes -- Long-haul COVID Symptoms in Person with Diabetes.

Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.

ISBN: 9783031285363$q(electronic bk.)

Standard No.: 10.1007/978-3-031-28536-3doiSubjects--Topical Terms:

937473
COVID-19 (Disease)
--Complications

LC Class. No.: RA644.C67

Dewey Class. No.: 616.24144

Diabetes and COVID-19considerations and clinical management /
LDR:03170nmm a2200337 a 4500 001 638152
003 DE-He213
005 20230610113711.0
006 m d
007 cr nn 008maaau
008 230921s2023 sz s 0 eng d
020 $a 9783031285363$q(electronic bk.)
020 $a 9783031285356$q(paper)
024 7 $a 10.1007/978-3-031-28536-3 $2 doi
035 $a 978-3-031-28536-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RA644.C67
072 7 $a MJG $2 bicssc
072 7 $a MED027000 $2 bisacsh
072 7 $a MJG $2 thema
082 0 4 $a 616.24144 $2 23
090 $a RA644.C67 $b D536 2023
245 0 0 $a Diabetes and COVID-19 $h [electronic resource] : $b considerations and clinical management / $c edited by Alyson K. Myers.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2023.
300 $a xviii, 219 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
490 1 $a Contemporary endocrinology, $x 2523-3793
505 0 $a COVID-19: epidemiology, etiology, clinical manifestations, diagnosis, therapeutic options, and prevention -- Pathophysiology: How COVID-19 Impacts the Pancreas and Peripheral Insulin Resistance -- Risk of COVID-19 in Persons with Diabetes -- Pathophysiology of Lung Dysfunction in Diabetes -- Diabetic kidney disease and COVID-19 -- The Impact of COVID-19 on Diabetic Foot Ulcers -- Co-morbid obesity and its impact on diabetes and COVID-19 -- Overview of Inpatient Mgt of Diabetes and COVID 19 -- Management of critically ill persons with COVID-19 and diabetes -- Managing Outpatient Diabetes in Persons with COVID-19 and Diabetes -- The Use of Diabetes Technology In Persons With Diabetes and Coronavirus 2019 (COVID-19) -- COVID-19 Vaccination in Persons with Diabetes -- COVID-19 Vaccination in Persons with Diabetes -- Long-haul COVID Symptoms in Person with Diabetes.
520 $a Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
650 0 $a COVID-19 (Disease) $x Complications $x Treatment. $3 937473
650 0 $a Diabetes $x Complications $x Treatment. $3 822534
650 1 4 $a Endocrinology. $3 196517
700 1 $a Myers, Alyson K. $3 944798
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Contemporary endocrinology. $3 558930
856 4 0 $u https://doi.org/10.1007/978-3-031-28536-3
950 $a Medicine (SpringerNature-11650)